CorMedix announced the appointment of Robert Stewart to the CorMedix Board of Directors. Following the appointment of Stewart, the Board will comprise 8 directors, 7 of which are independent. Stewart is the Chief Executive Officer of Theramex, a private equity backed, global specialty pharmaceutical company dedicated to women’s health, and has served in this role since March 2020.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CRMD:
- Cormedix Inc. Announces Appointment of Robert A. Stewart to Its Board of Directors
- CorMedix Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
- CorMedix reports Q4 EPS (20c), consensus (19c)
- Cormedix Inc. (CRMD) Q4 Earnings Cheat Sheet
- Cormedix Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update on March 30, 2023
